VolitionRX Limited (VNRX) Financials

VNRX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 18.0 million 20.9 million
2023-06-30 27.6 million 22.4 million
2023-03-31 18.0 million 21.0 million
2022-12-31 18.3 million 21.4 million

VNRX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -8.7 million 537980
2023-06-30 -7.6 million 592174
2023-03-31 -8.9 million 693657
2022-12-31 -5.8 million 706249

VNRX Net Income

No data available :(

VNRX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 10.8 million - 960398
2023-06-30 19.7 million 2.5 million 1.0 million
2023-03-31 10.0 million - 1.1 million
2022-12-31 10.9 million 2.8 million 1.1 million

VNRX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 78.2 million
2023-06-30 66.9 million
2023-03-31 60.2 million
2022-12-31 55.4 million

VNRX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 273041 4.7 million 3.9 million 156775
2023-06-30 301394 5.5 million 4.0 million 254768
2023-03-31 200592 4.9 million 4.0 million 227985
2022-12-31 578752 4.0 million 3.9 million 272288

VNRX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 165211 362467
2023-06-30 216310 351668
2023-03-31 149808 334577
2022-12-31 119715 307834

VNRX

Price: $0.89

52 week price:
0.55
2.10

Earnings Per Share: -0.50 USD

P/E Ratio: -2.17

Exchange: ASE

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 202636

Market Capitalization: 58.8 million

Links: